# MIRABEGRON
> **ANDA216757** · Abbreviated New Drug Application (Generic) · Sponsor: SUNSHINE LAKE PHARMA CO LTD · Approved 2025-12-10
## Drug
- **FDA Application Number:** ANDA216757
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** MIRABEGRON
- **Generic name:** Mirabegron
- **Active ingredients:** MIRABEGRON
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** —
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** SUNSHINE LAKE PHARMA CO LTD
- **First approval:** 2025-12-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216757)
---
*AI Analytics · CC0 1.0*